• Daily Marijuana Observer Facebook
  • Daily Marijuana Observer Twitter
  • Daily Marijuana Observer StockTwits
  • Daily Marijuana Observer SA
  • Daily Marijuana Observer Instagram
  • Daily Marijuana Observer Youtube
  • Pinterest Social Icon
  • Daily Marijuana Observer Talk Market

Zynerba Hosting Upcoming Clinical Research Day to Discuss CBD Gel

Today, Zynerba Pharmaceuticals, Inc. (NASDAQ:ZYNE) announced that they will be hosting a Clinical Research Day on December 15th. The purpose of Zynerba's event is to discuss "the potential role that ZYN002 CBD gel may play in providing relief for patients with debilitating conditions including epilepsy, osteoarthritis and Fragile X syndrome."


ZYN002 CBD Gel

ZYN002 CDB gel is absorbed through the skin or transdermally, rather than orally or otherwise. This allows for better absorption of the cannabinoids. This will allow for a more sustained, consistent, and controlled delivery method for cannabinoid treatment. 




The event will be held in New York City from 8:00 AM EST to 10:30 AM EST. Zynerba management as well as industry opinion leaders will be present and sharing their thoughts. Those interested in attending the event should contact Janet Cushey from Argot Partners at 212-600-1902 or janet@argotpartners.com. For those who wish to listen in via live webcast will be able to stream it from the investor relations section of Zynerba's website on the 15th and for 90 days following the event. 




For more information and custom stock charts for ZYNE, be sure to check out Zynerba Pharmaceuticals' stock profile in our marijuana stocks database. Also, don't forget to connect with us on social media using the links to the right of this article so you never miss a marijuana stock update. For Zynerba's press release regarding the Clinical Research Day, click here



Read more articles tagged:

Please reload

Please reload

Please reload


© Copyright 2016-2020 Smoke Show Ventures, Inc.

RSS Feed

Disclaimer: Except for the historical information and data presented herein, matters discussed in articles on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future performance or achievements expressed or implied by such coverage. Smoke Show Ventures, Inc., which owns The Daily Marijuana Observer, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. Smoke Show Ventures, Inc., which owns The Daily Marijuana Observer, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. Before making specific investment decisions, readers should seek their own professional advice and that of their own professional financial adviser. Smoke Show Ventures, Inc. or its affiliates, which owns The Daily Marijuana Observer, may be compensated for its services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.dailymarijuanaobserver.com/legal-disclaimer/.